Merck ( MRK ) recently announced that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for its insomnia candidate, suvorexant.
Read this article:
FDA Accepts Merck’s Sleep Drug NDA – Analyst Blog
Merck ( MRK ) recently announced that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for its insomnia candidate, suvorexant.
Read this article:
FDA Accepts Merck’s Sleep Drug NDA – Analyst Blog